Related Experiment Video
Updated: Apr 28, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Diterpenoids- potential chemopreventive and chemotherapeutic agents in leukemia
Swadesh Sarkar, Priya K Gopal, Santanu Paul1
1Laboratory of Experimental Immunology, Department of Botany and Microbiology, Gurudas College, Kolkata 700054, India. spaul_1971@yahoo.com.
Abstract:
Leukemia remains a major cause of death in both developing as well as developed nations worldwide. Development of novel therapeutic approaches is perceived to be the best strategy to combat this disease. Availability of limited effective drugs with least side effects is the major hurdle in treating leukemia. Another major concern remains initiation and engagement of therapeutic strategies that may subvert or overcome drug-resistance. Deployment of plant-based molecules in therapeutic engagements is regarded to be the most apt approach to combat different forms of leukemia. Diterpenoids of natural origin have a broad range of therapeutic activities including anti-leukemic effect. In vitro and in vivo studies establish many diterpenoids from natural sources and their synthetic derivatives to have appreciable cytotoxic and apoptotic efficacies against a series of leukemic cells. This paper attempts to identify and describe diterpenoids with their plant sources and analyze the molecular mechanistic approaches underlying their effective apoptotic activities against leukemic cells studied till date. The present review article summarizes different categories of diterpenoids having various degrees of anti-leukemic activities and discusses the measures of overcoming the bio-availability issues of these natural molecules so that they can serve as extremely viable options in future leukemia therapy.
Insights
Natural diterpenoids show potent anti-leukemic effects, offering a promising strategy against drug-resistant leukemia. Research explores their plant sources and mechanisms to improve bioavailability for future therapies.
Area of Science:
- Natural product chemistry
- Cancer biology
- Pharmacology
Background:
- Leukemia is a significant global health challenge with limited effective treatments.
- Drug resistance and side effects are major hurdles in current leukemia therapy.
- Plant-derived compounds are increasingly explored for novel therapeutic applications.
Purpose of the Study:
- To review diterpenoids from natural sources with anti-leukemic activity.
- To analyze the molecular mechanisms behind their cytotoxic and apoptotic effects.
- To discuss strategies for overcoming bioavailability issues of these natural molecules.
Main Methods:
- Literature review of in vitro and in vivo studies on diterpenoids.
- Analysis of reported plant sources and chemical structures.
- Examination of documented molecular mechanisms of action against leukemic cells.
Main Results:
- Diterpenoids exhibit significant cytotoxic and apoptotic efficacy against various leukemic cell lines.
- Natural and synthetic diterpenoids demonstrate broad anti-leukemic potential.
- Specific molecular pathways targeted by diterpenoids are identified.
Conclusions:
- Diterpenoids represent a viable class of natural compounds for leukemia treatment.
- Further research into their mechanisms and bioavailability can enhance their therapeutic application.
- Plant-based diterpenoids offer a promising avenue for combating drug-resistant leukemia.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drugs that Destabilize Microtubules
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

